Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis
US9574001B2 · kind B2 · utility
9Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2013 |
| Grant date | Feb 21, 2017 |
| Priority date | — |
| Expiry date | Aug 29, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods inhibiting tumor metastasis and treating cancer in a subject that involve administering to the subject an antibody which recognizes GPIIIa49-66, under conditions effective to inhibit tumor metastasis and/or treat cancer in the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.